United States Nanostructured Drug Market Report 2019

Table of Contents

United States Nanostructured Drug Market Report 2017
1 Nanostructured Drug Overview
1.1 Product Overview and Scope of Nanostructured Drug
1.2 Classification of Nanostructured Drug by Product Category
1.2.1 United States Nanostructured Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Nanostructured Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Liposomes
1.2.4 Polymeric Micelles
1.2.5 Solid lipid Nanoparticles
1.2.6 Microemulsion and Nanoemulsion
1.2.7 Nanosuspension
1.3 United States Nanostructured Drug Market by Application/End Users
1.3.1 United States Nanostructured Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 United States Nanostructured Drug Market by Region
1.4.1 United States Nanostructured Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Nanostructured Drug Status and Prospect (2012-2022)
1.4.3 Southwest Nanostructured Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Nanostructured Drug Status and Prospect (2012-2022)
1.4.5 New England Nanostructured Drug Status and Prospect (2012-2022)
1.4.6 The South Nanostructured Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Nanostructured Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nanostructured Drug (2012-2022)
1.5.1 United States Nanostructured Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Nanostructured Drug Revenue and Growth Rate (2012-2022)

2 United States Nanostructured Drug Market Competition by Players/Suppliers
2.1 United States Nanostructured Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nanostructured Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nanostructured Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Nanostructured Drug Market Competitive Situation and Trends
2.4.1 United States Nanostructured Drug Market Concentration Rate
2.4.2 United States Nanostructured Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nanostructured Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nanostructured Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Nanostructured Drug Sales and Market Share by Region (2012-2017)
3.2 United States Nanostructured Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Nanostructured Drug Price by Region (2012-2017)

4 United States Nanostructured Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Nanostructured Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nanostructured Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Nanostructured Drug Price by Type (2012-2017)
4.4 United States Nanostructured Drug Sales Growth Rate by Type (2012-2017)

5 United States Nanostructured Drug Sales (Volume) by Application (2012-2017)
5.1 United States Nanostructured Drug Sales and Market Share by Application (2012-2017)
5.2 United States Nanostructured Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nanostructured Drug Players/Suppliers Profiles and Sales Data
6.1 Merck
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nanostructured Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Nanostructured Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.2 Nanostructured Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Abbott
6.4.2 Nanostructured Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abbott Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
6.5.2 Nanostructured Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GlaxoSmithKline Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 Nanostructured Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sanofi
6.7.2 Nanostructured Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sanofi Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly
6.8.2 Nanostructured Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Astrazeneca
6.9.2 Nanostructured Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astrazeneca Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
6.10.2 Nanostructured Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Johnson & Johnson Nanostructured Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Celgene
6.12 Novavax
6.13 Stryker
6.14 Gilead Sciences
6.15 OSI Pharmaceuticals
6.16 Kadmon Pharmaceuticals
6.17 Samyang Biopharm
6.18 Mitsubishi Pharma
6.19 Kaken Pharmaceutical
6.20 Selecta Biosciences
6.21 Par Pharmaceutical
6.22 Cerulean Pharma
6.23 Navidea Biopharmaceuticals
6.24 Lummy

7 Nanostructured Drug Manufacturing Cost Analysis
7.1 Nanostructured Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nanostructured Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nanostructured Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nanostructured Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nanostructured Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Nanostructured Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nanostructured Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Nanostructured Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Nanostructured Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Nanostructured Drug
Figure United States Nanostructured Drug Market Size (K Doses) by Type (2012-2022)
Figure United States Nanostructured Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Liposomes Product Picture
Figure Polymeric Micelles Product Picture
Figure Solid lipid Nanoparticles Product Picture
Figure Microemulsion and Nanoemulsion Product Picture
Figure Nanosuspension Product Picture
Figure United States Nanostructured Drug Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Nanostructured Drug by Application in 2016
Figure Cancer and Tumors Examples
Table Key Downstream Customer in Cancer and Tumors
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure United States Nanostructured Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nanostructured Drug Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Nanostructured Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nanostructured Drug Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Nanostructured Drug Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Nanostructured Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nanostructured Drug Sales Share by Players/Suppliers
Figure 2017 United States Nanostructured Drug Sales Share by Players/Suppliers
Figure United States Nanostructured Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nanostructured Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nanostructured Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nanostructured Drug Revenue Share by Players/Suppliers
Figure 2017 United States Nanostructured Drug Revenue Share by Players/Suppliers
Table United States Market Nanostructured Drug Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Nanostructured Drug Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Nanostructured Drug Market Share of Top 3 Players/Suppliers
Figure United States Nanostructured Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nanostructured Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nanostructured Drug Product Category
Table United States Nanostructured Drug Sales (K Doses) by Region (2012-2017)
Table United States Nanostructured Drug Sales Share by Region (2012-2017)
Figure United States Nanostructured Drug Sales Share by Region (2012-2017)
Figure United States Nanostructured Drug Sales Market Share by Region in 2016
Table United States Nanostructured Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nanostructured Drug Revenue Share by Region (2012-2017)
Figure United States Nanostructured Drug Revenue Market Share by Region (2012-2017)
Figure United States Nanostructured Drug Revenue Market Share by Region in 2016
Table United States Nanostructured Drug Price (USD/Dose) by Region (2012-2017)
Table United States Nanostructured Drug Sales (K Doses) by Type (2012-2017)
Table United States Nanostructured Drug Sales Share by Type (2012-2017)
Figure United States Nanostructured Drug Sales Share by Type (2012-2017)
Figure United States Nanostructured Drug Sales Market Share by Type in 2016
Table United States Nanostructured Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nanostructured Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nanostructured Drug by Type (2012-2017)
Figure Revenue Market Share of Nanostructured Drug by Type in 2016
Table United States Nanostructured Drug Price (USD/Dose) by Types (2012-2017)
Figure United States Nanostructured Drug Sales Growth Rate by Type (2012-2017)
Table United States Nanostructured Drug Sales (K Doses) by Application (2012-2017)
Table United States Nanostructured Drug Sales Market Share by Application (2012-2017)
Figure United States Nanostructured Drug Sales Market Share by Application (2012-2017)
Figure United States Nanostructured Drug Sales Market Share by Application in 2016
Table United States Nanostructured Drug Sales Growth Rate by Application (2012-2017)
Figure United States Nanostructured Drug Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Merck Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Merck Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Pfizer Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Pfizer Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Novartis Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Novartis Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Novartis Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Abbott Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Abbott Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Abbott Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Nanostructured Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Roche Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Roche Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Roche Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Sanofi Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Eli Lilly Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Astrazeneca Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Astrazeneca Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Astrazeneca Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Nanostructured Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Johnson & Johnson Nanostructured Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Nanostructured Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Nanostructured Drug Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Novavax Basic Information List
Table Stryker Basic Information List
Table Gilead Sciences Basic Information List
Table OSI Pharmaceuticals Basic Information List
Table Kadmon Pharmaceuticals Basic Information List
Table Samyang Biopharm Basic Information List
Table Mitsubishi Pharma Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Selecta Biosciences Basic Information List
Table Par Pharmaceutical Basic Information List
Table Cerulean Pharma Basic Information List
Table Navidea Biopharmaceuticals Basic Information List
Table Lummy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanostructured Drug
Figure Manufacturing Process Analysis of Nanostructured Drug
Figure Nanostructured Drug Industrial Chain Analysis
Table Raw Materials Sources of Nanostructured Drug Major Players/Suppliers in 2016
Table Major Buyers of Nanostructured Drug
Table Distributors/Traders List
Figure United States Nanostructured Drug Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Nanostructured Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nanostructured Drug Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Nanostructured Drug Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Nanostructured Drug Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Nanostructured Drug Sales Volume (K Doses) Forecast by Type in 2022
Table United States Nanostructured Drug Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Nanostructured Drug Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Nanostructured Drug Sales Volume (K Doses) Forecast by Application in 2022
Table United States Nanostructured Drug Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Nanostructured Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nanostructured Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nanostructured Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources